Need Help?

Epigenome-wide association study of cocaine use disorder in postmortem human brain tissue

Analysis of cocaine use disorder (CUD) associated epigenome-wide DNA methylation (DNAm) alterations in human postmortem brain tissue of Brodmann Area 9. Tissue samples from N=21 CUD cases and N=21 individuals without CUD originating from the Douglas Bell Canada Brain Bank (DBCBB) were included. Epigenome-wide DNAm was investigated using the Illumina Infinium MethylationEPIC array.

Request Access

Data access agreement

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom CIMH grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: CIMH and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. CIMH: Central Institute of Mental Health J5 68159 Mannheim Germany 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify CIMH within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify CIMH prior to any significant changes to the protocol for the Project. 14. The User Institution will notify CIMH as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. CIMH may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than CIMH. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of Germany and shall be subject to the exclusive jurisdiction of the German courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001006826 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00007829860 idat 13.7 MB
EGAF00007829861 idat 13.7 MB
EGAF00007829862 idat 13.7 MB
EGAF00007829863 idat 13.7 MB
EGAF00007829864 idat 13.7 MB
EGAF00007829865 idat 13.7 MB
EGAF00007829866 idat 13.7 MB
EGAF00007829867 idat 13.7 MB
EGAF00007829868 idat 13.7 MB
EGAF00007829869 idat 13.7 MB
EGAF00007829870 idat 13.7 MB
EGAF00007829871 idat 13.7 MB
EGAF00007829872 idat 13.7 MB
EGAF00007829873 idat 13.7 MB
EGAF00007829874 idat 13.7 MB
EGAF00007829875 idat 13.7 MB
EGAF00007829876 idat 13.7 MB
EGAF00007829877 idat 13.7 MB
EGAF00007829878 idat 13.7 MB
EGAF00007829879 idat 13.7 MB
EGAF00007829880 idat 13.7 MB
EGAF00007829881 idat 13.7 MB
EGAF00007829882 idat 13.7 MB
EGAF00007829883 idat 13.7 MB
EGAF00007829884 idat 13.7 MB
EGAF00007829885 idat 13.7 MB
EGAF00007829886 idat 13.7 MB
EGAF00007829887 idat 13.7 MB
EGAF00007829888 idat 13.7 MB
EGAF00007829889 idat 13.7 MB
EGAF00007829890 idat 13.7 MB
EGAF00007829891 idat 13.7 MB
EGAF00007829892 idat 13.7 MB
EGAF00007829893 idat 13.7 MB
EGAF00007829894 idat 13.7 MB
EGAF00007829895 idat 13.7 MB
EGAF00007829896 idat 13.7 MB
EGAF00007829897 idat 13.7 MB
EGAF00007829898 idat 13.7 MB
EGAF00007829899 idat 13.7 MB
EGAF00007829900 idat 13.7 MB
EGAF00007829901 idat 13.7 MB
EGAF00007829902 idat 13.7 MB
EGAF00007829903 idat 13.7 MB
EGAF00007829904 idat 13.7 MB
EGAF00007829905 idat 13.7 MB
EGAF00007829906 idat 13.7 MB
EGAF00007829907 idat 13.7 MB
EGAF00007829908 idat 13.7 MB
EGAF00007829909 idat 13.7 MB
EGAF00007829910 idat 13.7 MB
EGAF00007829911 idat 13.7 MB
EGAF00007829912 idat 13.7 MB
EGAF00007829913 idat 13.7 MB
EGAF00007829914 idat 13.7 MB
EGAF00007829915 idat 13.7 MB
EGAF00007829916 idat 13.7 MB
EGAF00007829917 idat 13.7 MB
EGAF00007829918 idat 13.7 MB
EGAF00007829919 idat 13.7 MB
EGAF00007829920 idat 13.7 MB
EGAF00007829921 idat 13.7 MB
EGAF00007829922 idat 13.7 MB
EGAF00007829923 idat 13.7 MB
EGAF00007829924 idat 13.7 MB
EGAF00007829925 idat 13.7 MB
EGAF00007829926 idat 13.7 MB
EGAF00007829927 idat 13.7 MB
EGAF00007829928 idat 13.7 MB
EGAF00007829929 idat 13.7 MB
EGAF00007829930 idat 13.7 MB
EGAF00007829931 idat 13.7 MB
EGAF00007829932 idat 13.7 MB
EGAF00007829933 idat 13.7 MB
EGAF00007829934 idat 13.7 MB
EGAF00007829935 idat 13.7 MB
EGAF00007829936 idat 13.7 MB
EGAF00007829937 idat 13.7 MB
EGAF00007829938 idat 13.7 MB
EGAF00007829939 idat 13.7 MB
EGAF00007829940 idat 13.7 MB
EGAF00007829941 idat 13.7 MB
EGAF00007829942 idat 13.7 MB
EGAF00007829943 idat 13.7 MB
84 Files (1.1 GB)